Sep 22, 2015
The CardioMEMS™ HF System is the first Food and Drug Administration (FDA)-approved heart failure (HF) monitor proven to significantly reduce HF hospital admissions and improve quality of life in NYHA class III patients. This implanted, wireless, battery-free device measures key vital signs, including pulmonary artery pressure in HF patients, and transmits this information remotely to the patient’s doctors for proactive management.
A new device, bioabsorbable cardiac matrix (BCM), was just investigated in a randomized, double-blind, placebo-controlled trial to determine its safety and efficacy in preventing ventricular remodeling and congestive heart failure (CHF), when administered to subjects who had successful percutaneous coronary intervention (PCI) with stent placement after ST-elevation myocardial infarction (STEMI). Penn State Hershey Medical Center participated in this multi-center trial named PRESERVATION I.
Sep 4, 2015
Two phase 1 trials at Penn State Health Milton S. Hershey Medical Center focused on preventing the recurrence of glioblastoma multiforme by targeting cancer stem cells traditionally resistant to any form of treatment.
Sep 3, 2015
For the first time, a new online tool is helping pediatricians and parents determine worrisome amounts of weight loss in breastfed newborns. The Newborn Weight Tool, or NEWT, is an interactive weight loss chart using data from more than 100,000 exclusively breastfed babies born between 2009 and 2013. It was developed by Ian Paul, M.D., […]
More than 15,000 children are diagnosed with cancer each year in the U.S., and while 80 percent of children survive, one in five die within five years.1 Penn State Hershey is committed to improving those outcomes through its Four Diamonds’ Pediatric Oncology Research Center. The Center has been led by Chief of Pediatric Oncology Barbara […]
Aug 21, 2015
Successful combined use of the Ilizarov technique and Taylor spatial frame spared a healthy mother of two from the amputation of her left leg (above the knee) following a traumatic accident; the team was able to save her knee and work to heal it before any amputation needed to occur.
A magnetically controlled growing rod system (MAGnetic Expansion Control, MAGEC™) was approved by the United States Food and Drug Administration for treatment of early onset scoliosis in February 2014. Used in Europe since 2009, MAGEC provides a nonsurgical distraction alternative to conventional growing rod systems.
Distal radius fractures are the most common type of fracture treated in emergency departments. According to Alexander H. Payatakes, MD, Penn State Bone and Joint Institute, “The vast majority of operative distal radius fractures can be successfully treated with a volar locking plate."
Jul 16, 2015
A multi-center, investigator-initiated epidemiologic study is underway aiming to determine the proportion of adults affected by late-onset lysosomal acid lipase deficiency (LAL-D) using definitive genetic testing.
Jul 3, 2015
Fertility preservation is now within reach for nearly all post-pubertal, premenopausal female cancer patients. In 2013, the American Society for Reproductive Medicine published a clear opinion, stating “Clinicians should inform patients…about options for fertility preservation and future reproduction prior to the initiation of [gonadotoxic therapies].”¹ Oocyte and embryo cryopreservation are considered non-experimental procedures, thanks to […]
